These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 39141682)

  • 1. Reactive Oxygen Species-Responsive Nanoparticle Delivery of Small Interfering Ribonucleic Acid Targeting Olfactory Receptor 2 for Atherosclerosis Theranostics.
    Ni H; Zhou H; Liang X; Ge Y; Chen H; Liu J; Wang B; Chen H; Zhang Y; Luo S; Chen Y; Lu X; Yin C; Fan Q
    ACS Nano; 2024 Aug; 18(34):23599-23614. PubMed ID: 39141682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olfactory receptor 2 in vascular macrophages drives atherosclerosis by NLRP3-dependent IL-1 production.
    Orecchioni M; Kobiyama K; Winkels H; Ghosheh Y; McArdle S; Mikulski Z; Kiosses WB; Fan Z; Wen L; Jung Y; Roy P; Ali AJ; Miyamoto Y; Mangan M; Makings J; Wang Z; Denn A; Vallejo J; Owens M; Durant CP; Braumann S; Mader N; Li L; Matsunami H; Eckmann L; Latz E; Wang Z; Hazen SL; Ley K
    Science; 2022 Jan; 375(6577):214-221. PubMed ID: 35025664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corilagin alleviates atherosclerosis by inhibiting NLRP3 inflammasome activation via the Olfr2 signaling pathway
    Mao J; Chen Y; Zong Q; Liu C; Xie J; Wang Y; Fisher D; Hien NTT; Pronyuk K; Musabaev E; Li Y; Zhao L; Dang Y
    Front Immunol; 2024; 15():1364161. PubMed ID: 38803504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Odorant receptors in macrophages: potential targets for atherosclerosis.
    Wang C; Andreasson KI
    Trends Immunol; 2022 Apr; 43(4):262-264. PubMed ID: 35283015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin Ameliorates the Progression of Atherosclerosis via Mitophagy Activation and NLRP3 Inflammasome Inhibition.
    Ma S; Chen J; Feng J; Zhang R; Fan M; Han D; Li X; Li C; Ren J; Wang Y; Cao F
    Oxid Med Cell Longev; 2018; 2018():9286458. PubMed ID: 30254716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nano-Antagonist Alleviates Inflammation and Allows for MRI of Atherosclerosis.
    Mog B; Asase C; Chaplin A; Gao H; Rajagopalan S; Maiseyeu A
    Nanotheranostics; 2019; 3(4):342-355. PubMed ID: 31723548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.
    van der Heijden T; Kritikou E; Venema W; van Duijn J; van Santbrink PJ; Slütter B; Foks AC; Bot I; Kuiper J
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1457-1461. PubMed ID: 28596375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VCAM-1-binding peptide targeted cationic liposomes containing NLRP3 siRNA to modulate LDL transcytosis as a novel therapy for experimental atherosclerosis.
    Jia X; Bai X; Yang X; Wang L; Lu Y; Zhu L; Zhao Y; Cheng W; Shu M; Mei Q; Jin S
    Metabolism; 2022 Oct; 135():155274. PubMed ID: 35917895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficient Chaperone-Mediated Autophagy Promotes Inflammation and Atherosclerosis.
    Qiao L; Ma J; Zhang Z; Sui W; Zhai C; Xu D; Wang Z; Lu H; Zhang M; Zhang C; Chen W; Zhang Y
    Circ Res; 2021 Dec; 129(12):1141-1157. PubMed ID: 34704457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GP73 enhances the ox-LDL-induced inflammatory response in THP-1 derived macrophages via affecting NLRP3 inflammasome signaling.
    Lin YF; Li MH; Huang RH; Zhang SZ; Xu XF; Zhou HM; Liu MH; Liao XX; Liao LZ; Guo Y; Zhuang XD
    Int J Cardiol; 2023 Sep; 387():131109. PubMed ID: 37271284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ogg1-Dependent DNA Repair Regulates NLRP3 Inflammasome and Prevents Atherosclerosis.
    Tumurkhuu G; Shimada K; Dagvadorj J; Crother TR; Zhang W; Luthringer D; Gottlieb RA; Chen S; Arditi M
    Circ Res; 2016 Sep; 119(6):e76-90. PubMed ID: 27384322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near-Infrared II Fluorescence Imaging and Image-Guided siRNA Therapy of Atherosclerosis.
    Gao J; Yu K; Luo Q; Deng M; Hou X; Wang W; Zeng X; Xiong X; He Y; Hong X; Xiao Y
    J Med Chem; 2024 Jul; 67(14):12428-12438. PubMed ID: 38996002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
    Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
    Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Role for Tranilast in Regulating NLRP3 Ubiquitination, Vascular Inflammation, and Atherosclerosis.
    Chen S; Wang Y; Pan Y; Liu Y; Zheng S; Ding K; Mu K; Yuan Y; Li Z; Song H; Jin Y; Fu J
    J Am Heart Assoc; 2020 Jun; 9(12):e015513. PubMed ID: 32476536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice.
    Wang R; Wang Y; Mu N; Lou X; Li W; Chen Y; Fan D; Tan H
    Lab Invest; 2017 Aug; 97(8):922-934. PubMed ID: 28394319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophages regulate plaque progression in diabetic Apoe
    Liu WX; Hu YF; Tai GJ; Li YP; Li JP; Qiu S; Zheng RF; Damdinjav D; Otieno JN; Li XX; Xu M
    Atherosclerosis; 2024 Oct; 397():118556. PubMed ID: 39222595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of siRNA nanoparticles to silence plaque-destabilizing gene in atherosclerotic lesional macrophages.
    Huang X; Liu C; Kong N; Xiao Y; Yurdagul A; Tabas I; Tao W
    Nat Protoc; 2022 Mar; 17(3):748-780. PubMed ID: 35121853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p38δ MAPK: A Novel Regulator of NLRP3 Inflammasome Activation With Increased Expression in Coronary Atherogenesis.
    Rajamäki K; Mäyränpää MI; Risco A; Tuimala J; Nurmi K; Cuenda A; Eklund KK; Öörni K; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1937-46. PubMed ID: 27417584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NLRP3 Inflammasome Activation Controls Vascular Smooth Muscle Cells Phenotypic Switch in Atherosclerosis.
    Burger F; Baptista D; Roth A; da Silva RF; Montecucco F; Mach F; Brandt KJ; Miteva K
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fucoidan Inhibits NLRP3 Inflammasome Activation by Enhancing p62/SQSTM1-Dependent Selective Autophagy to Alleviate Atherosclerosis.
    Cheng Y; Pan X; Wang J; Li X; Yang S; Yin R; Ma A; Zhu X
    Oxid Med Cell Longev; 2020; 2020():3186306. PubMed ID: 33505579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.